In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis

Lung-resident mesenchymal stem cells (LR-MSC) are thought to participate in idiopathic pulmonary fibrosis (IPF) by differentiating into myofibroblasts. On the other hand, LR-MSC in IPF patients present senescence-related features. It is unclear how they respond to a profibrotic environment. Here, we...

Full description

Bibliographic Details
Main Authors: Gabriel Escarrer-Garau, Aina Martín-Medina, Joan Truyols-Vives, Cristina Gómez-Bellvert, Linda Elowsson, Gunilla Westergren-Thorsson, Maria Molina-Molina, Josep Mercader-Barceló, Ernest Sala-Llinàs
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/2/160
_version_ 1797339939451437056
author Gabriel Escarrer-Garau
Aina Martín-Medina
Joan Truyols-Vives
Cristina Gómez-Bellvert
Linda Elowsson
Gunilla Westergren-Thorsson
Maria Molina-Molina
Josep Mercader-Barceló
Ernest Sala-Llinàs
author_facet Gabriel Escarrer-Garau
Aina Martín-Medina
Joan Truyols-Vives
Cristina Gómez-Bellvert
Linda Elowsson
Gunilla Westergren-Thorsson
Maria Molina-Molina
Josep Mercader-Barceló
Ernest Sala-Llinàs
author_sort Gabriel Escarrer-Garau
collection DOAJ
description Lung-resident mesenchymal stem cells (LR-MSC) are thought to participate in idiopathic pulmonary fibrosis (IPF) by differentiating into myofibroblasts. On the other hand, LR-MSC in IPF patients present senescence-related features. It is unclear how they respond to a profibrotic environment. Here, we investigated the profibrotic response of LR-MSC isolated from IPF and control (CON) patients. LR-MSC were inoculated in mice 48 h after bleomycin (BLM) instillation to analyze their contribution to lung damage. In vitro, LR-MSC were exposed to TGFβ. Mice inoculated with IPF LR-MSC exhibited worse maintenance of their body weight. The instillation of either IPF or CON LR-MSC sustained BLM-induced histological lung damage, bronchoalveolar lavage fluid cell count, and the expression of the myofibroblast marker, extracellular matrix (ECM) proteins, and proinflammatory cytokines in the lungs. In vitro, IPF LR-MSC displayed higher basal protein levels of aSMA and fibronectin than CON LR-MSC. However, the TGFβ response in the expression of TGFβ, aSMA, and ECM genes was attenuated in IPF LR-MSC. In conclusion, IPF LR-MSC have acquired myofibroblastic features, but their capacity to further respond to profibrotic stimuli seems to be attenuated. In an advanced stage of the disease, LR-MSC may participate in disease progression owing to their limited ability to repair epithelial damage.
first_indexed 2024-03-08T09:55:47Z
format Article
id doaj.art-6138692926f04a3bb494e28fe6e54efa
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-08T09:55:47Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-6138692926f04a3bb494e28fe6e54efa2024-01-29T13:50:28ZengMDPI AGCells2073-44092024-01-0113216010.3390/cells13020160In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary FibrosisGabriel Escarrer-Garau0Aina Martín-Medina1Joan Truyols-Vives2Cristina Gómez-Bellvert3Linda Elowsson4Gunilla Westergren-Thorsson5Maria Molina-Molina6Josep Mercader-Barceló7Ernest Sala-Llinàs8MolONE Research Group, University of the Balearic Islands (UIB), 07122 Palma, SpainiRESPIRE Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, SpainMolONE Research Group, University of the Balearic Islands (UIB), 07122 Palma, SpainPathological Anatomy Service, Son Espases University Hospital, 07120 Palma, SpainLung Biology, Department of Experimental Medical Science, Lund University, 08908 Lund, SwedenLung Biology, Department of Experimental Medical Science, Lund University, 08908 Lund, SwedenILD Unit, Respiratory Department, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, SpainMolONE Research Group, University of the Balearic Islands (UIB), 07122 Palma, SpainiRESPIRE Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, SpainLung-resident mesenchymal stem cells (LR-MSC) are thought to participate in idiopathic pulmonary fibrosis (IPF) by differentiating into myofibroblasts. On the other hand, LR-MSC in IPF patients present senescence-related features. It is unclear how they respond to a profibrotic environment. Here, we investigated the profibrotic response of LR-MSC isolated from IPF and control (CON) patients. LR-MSC were inoculated in mice 48 h after bleomycin (BLM) instillation to analyze their contribution to lung damage. In vitro, LR-MSC were exposed to TGFβ. Mice inoculated with IPF LR-MSC exhibited worse maintenance of their body weight. The instillation of either IPF or CON LR-MSC sustained BLM-induced histological lung damage, bronchoalveolar lavage fluid cell count, and the expression of the myofibroblast marker, extracellular matrix (ECM) proteins, and proinflammatory cytokines in the lungs. In vitro, IPF LR-MSC displayed higher basal protein levels of aSMA and fibronectin than CON LR-MSC. However, the TGFβ response in the expression of TGFβ, aSMA, and ECM genes was attenuated in IPF LR-MSC. In conclusion, IPF LR-MSC have acquired myofibroblastic features, but their capacity to further respond to profibrotic stimuli seems to be attenuated. In an advanced stage of the disease, LR-MSC may participate in disease progression owing to their limited ability to repair epithelial damage.https://www.mdpi.com/2073-4409/13/2/160idiopathic pulmonary fibrosislung-resident mesenchymal stem celltransforming growth factor βbleomycininflammationextracellular matrix proteins
spellingShingle Gabriel Escarrer-Garau
Aina Martín-Medina
Joan Truyols-Vives
Cristina Gómez-Bellvert
Linda Elowsson
Gunilla Westergren-Thorsson
Maria Molina-Molina
Josep Mercader-Barceló
Ernest Sala-Llinàs
In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
Cells
idiopathic pulmonary fibrosis
lung-resident mesenchymal stem cell
transforming growth factor β
bleomycin
inflammation
extracellular matrix proteins
title In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
title_full In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
title_fullStr In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
title_full_unstemmed In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
title_short In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
title_sort in vivo and in vitro pro fibrotic response of lung resident mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
topic idiopathic pulmonary fibrosis
lung-resident mesenchymal stem cell
transforming growth factor β
bleomycin
inflammation
extracellular matrix proteins
url https://www.mdpi.com/2073-4409/13/2/160
work_keys_str_mv AT gabrielescarrergarau invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT ainamartinmedina invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT joantruyolsvives invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT cristinagomezbellvert invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT lindaelowsson invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT gunillawestergrenthorsson invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT mariamolinamolina invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT josepmercaderbarcelo invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis
AT ernestsalallinas invivoandinvitroprofibroticresponseoflungresidentmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis